| James S Good, MD | |
|
2825 8th Ave N, Billings, MT 59101-0909 | |
| (406) 238-2500 | |
| Not Available |
| Full Name | James S Good |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 2825 8th Ave N, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154433662 | NPI | - | NPPES |
| 0011186 | Other | MT | MDCD PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 3608 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James S Good, MD Po Box 35100, Billings, MT 59107-5100 Ph: (406) 238-2500 | James S Good, MD 2825 8th Ave N, Billings, MT 59101-0909 Ph: (406) 238-2500 |
News Archive
When a soldier sustains a traumatic eye injury on the battlefield, any delay in treatment may lead to permanent vision loss. With medical facilities potentially far away and no existing tools to prevent deterioration, medics are in a high-stakes race against the clock.
Scientists at the Karlsruhe Institute of Technology (KIT) have come up with a miniaturized and accelerated system of new drug development on just one chip, promising to make the process faster and cheaper than ever before. The report was published in the journal Nature Communications on June 28, 2019.
Those who struggle in social situations may be at greater risk for mental and physical health problems, according to a new study from the University of Arizona.
Australian researchers have uncovered a secret communication hotline between breast cancers and the normal cells surrounding them. Importantly, the messages sent back and forth between the normal and tumour cells encourage the cancer to survive and to become more aggressive.
Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc. U.S., submitted a New Drug Application to the U.S. Food and Drug Administration for an investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone for the treatment of hypertension, or high blood pressure.
› Verified 1 days ago
Jerald A. Bell, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2501 | |
Deborah G. Keenum, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Daniel T. Weaver, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
James Randall, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1221 N 26th St, Billings, MT 59101 Phone: 406-252-5681 Fax: 406-252-5025 | |
James Peter Cornetet, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
James Thomas Priddy, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4033 Avenue B, Billings, MT 59106 Phone: 406-256-6000 Fax: 406-256-9006 |